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ABSTRACT
Introduction: Rheumatoid arthritis (RA) is a chronic, systemic, inﬂ  ammatory disease, which is associated 
with an excess of cardiovascular events. A decrease in the compliance of the arterial system, termed arterial 
stiffness, results in increased cardiac workload. Primary prevention of cardiovascular disease (CVD) is a priority 
for modern medicine. Therefore, further studies are required to explore the mechanisms through which CVD 
increases in RA. Patients and Methods: This case–control study was performed to detect possible change of 
aortic elasticity in patients with RA, and to estimate the impact of different cardiovascular and atherogenic 
risk factors on the severity of arterial stiffness. Sixty-three consecutive adults with RA were enrolled for the 
study (case group). Forty-one healthy adults matched for age and gender were considered as a control group. 
All were subjected to assessment of aortic stiffness index and various cardiovascular risk factors. Patients with 
rheumatoid disease (case group) were divided by their aortic stiffness index status to two groups (A and B, with 
and without aortic stiffness, respectively). Results: Aortic stiffness was present in 31.7% of the RA patients. 
Age of the patients, duration of RA, smoking index, waist circumference, triglycerides levels, and CRP were 
signiﬁ  cantly higher in patients with aortic stiffness. Conclusion: RA is associated with decreased elasticity 
of the aorta in both genders, and such changes seem to be higher in the presence of visceral obesity, smoking, 
high triglycerides, and extraarticular disease severity.
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INTRODUCTION
Rheumatoid arthritis (RA) is a chronic, systemic, 
inﬂ  ammatory disease.[1] It is associated with an increased 
mortality compared with the general population, mainly 
due to an excess of deaths from cardiovascular disease 
(CVD).[2-4] Disability and severe extraarticular disease 
manifestations are predictors of poor survival in patients 
with RA.[5]
Hyperglycemia, hypertension, dyslipidemia, obesity, 
smoking, and aging are associated with high risk of CVD 
as well as other clinical conditions.[6] The mechanisms 
through which cardiovascular risk is increased are partially 
understood. A decrease in the compliance of the central 
arterial system, termed arterial stiffness, results in increased 
cardiac workload.[7] Some studies had revealed that aortic 
stiffness, wave-reﬂ  ection intensity, and endothelial function 
are independent predictors of cardiovascular risk in 
various patient groups and may also directly accelerate the 
atherosclerotic process.[8-10]
A number of factors are believed to be responsible for 
arterial stiffness, which include decreased elastin and 
increased collagen in the arterial wall, and abnormal 
endothelial regulation of arterial smooth muscle tone.[6]
Primary prevention of CVD is a priority for modern 
medicine.[1,11] Therefore, there is the need for more studies 
to explore the mechanisms through which CVD increases 
in RA. This study was undertaken in order to study the 
distensibility of elastic aorta in patients with RA, and 
to estimate the impact of different cardiovascular and 
atherogenic risk factors on the severity of arterial stiffness.Sliem and Nasr: Aortic elasticity in rheumatoid arthritis
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PATIENTS AND METHODS
Patient selection
A case–control study was performed. Sixty-three 
consecutive adults with RA were enrolled for the study 
(case group). All were recruited from the outpatient 
rheumatology, cardiology, and internal medicine clinics of 
Suez Canal University Hospital from May 2007 to February 
2008. Forty-one healthy adults matched for age and gender 
were considered as a control group.
The diagnosis of RA was defined according to the 
proposed American College of Rheumatology criteria: 
1. Morning stiffness, 2. Arthritis of three or more joint 
areas, 3. Arthritis of hand joints, 4. Symmetric arthritis, 5. 
Rheumatoid nodules, 6. Serum rheumatoid factor, and 7. 
Radiographic changes. A patient was diagnosed as RA if 
he/she had satisﬁ  ed at least four of these seven criteria. 
Criteria 1 through 4 must have been present for at least 
6 weeks.[12] Patients with chronic liver, chronic kidney, 
personal or family history of overt CVDs, other rheumatic 
or collagen diseases were excluded from the study.
All groups were subjected to full medical history, clinical 
examination including blood pressure (BP), body 
mass index (BMI), systemic examination, biochemical 
radiological, and echocardiographic studies. Smoking 
index was calculated as the product of the number of 
cigarettes smoked per day and the number of years for 
which they had been smoked.[13] BMI was calculated as 
weight/height2 (kg/m2) and was used as an estimate of 
overall adiposity. Waist circumference, a validated estimate 
of visceral adiposity, was measured to the nearest 0.5 cm. 
Central obesity was deﬁ  ned as (circumference > 102 cm 
in males and >88 cm in females).[14] BP was measured 
from the brachial artery with a manual cuff, and mean 
arterial pressure (MAP) was calculated using the formula 
MAP = DBP + (SBP – DBP)/3, where SBP is systolic 
blood pressure and DBP is diastolic blood pressure.[15] 
CRP assay via chemiluminescence using IMMULITE/
IMMULITE 1000 reagent. Cholesterol, triglycerides, high-
density lipoproteins, blood glucose, and rheumatoid factor 
via automated HITACHI 92 autoanalyzer and automated 
OBAS INTEGRA 400 autoanalyzer.
Aortic stiffness index (β) as a characteristic of aortic 
elasticity was evaluated from ascending aortic diameter. 
Aortic stiffness index (β) was evaluated by means of 
transthoracic echocardiography by use of the formula: 
β = ln(SBP/DBP)/(ΔD/DD), where SBP and DBP are 
the systolic and diastolic BPs , DD is the diastolic aortic 
diameter, ΔD is the pulsatile change in aortic diameter 
(systolic diameter minus diastolic diameter) and ‘ln’ is the 
natural logarithm).[8,16]
Patients with rheumatoid disease (case group) were divided 
by their aortic stiffness index status at baseline (β above 
and below median of 3.0) to two groups (A and B, with 
and without aortic stiffness, respectively). The median was 
based on the overall control group at baseline.
Ethical consideration
Informed consent was obtained from all the adults. The aim 
and the value of the work were explained in a simpliﬁ  ed 
manner for them. There was no harm inﬂ  icted on them. On 
the contrary, all had beneﬁ  ts of the follow-up and the ﬁ  nal 
results of the study. The study was approved by the Ethics 
Committee of Faculty of Medicine, Suez Canal University.
Statistical analysis
According to the type of data, the student’s unpaired 
t-test and Chi-square test were used for statistical 
comparisons of two groups. Descriptive statistics were 
done including mean, standard deviation, mode and median 
for quantitative variables, and frequency and percent for 
qualitative variables. The analysis was carried out by a 
computer program (SPSS Ver. 11). P value was set at <0.05 
for statistically signiﬁ  cant results and <0.0001 for highly 
signiﬁ  cant results.
RESULTS 
Baseline demographic and clinical characteristics of 63 (33 
males and 30 females) RA patients, mean age 44.1 years, 
with and without aortic stiffness versus 41 control (22 males 
and 19 females), mean age 45.8 years are shown in Table 1. 
Of them, 31.7% of the patients had aortic stiffness (Group 
A). No signiﬁ  cant differences were observed between 
both patient and control groups in terms of age, gender 
distribution, BMI, and BP. Except waist circumference, all 
mentioned clinical parameters were nearly similar in both 
male and female patients. Mean of age, smoking index, 
duration of RA, percent of extraarticular manifestations 
were signiﬁ  cantly higher in Group A than that of Group 
B. All RA patients were treated by nonsteroidal anti-
inﬂ  ammatory drugs. Methotrexate was taken by 17 cases 
(27%), 5 in Group A (25%) and 12 in Group B (28%).
Baseline biochemical characteristics are presented in 
Table 2. Mean values of triglycerides and C-reactive protein 
(CRP) were signiﬁ  cantly higher in Group A than that of 
Group B. On the other hand, mean values of low- and Sliem and Nasr: Aortic elasticity in rheumatoid arthritis
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high-density lipoproteins, fasting plasma glucose, and 
rheumatoid factor percents were similar in both Group A 
and Group B. Similarly, no differences were found with 
overall patients and control variables.
Regarding aortic stiffness index, signiﬁ  cant difference 
was observed between all patients’ cases and control 
group. In addition, highly signiﬁ  cant difference was 
observed between Group A and both Group B and 
control [Figure 1].
DISCUSSION
RA is a systemic disease associated with increased mortality, 
mostly due to an excess of CVD.[17] In recent years, great 
attention has been paid to the role of changes in the 
stiffness of the large arteries, such as the aorta and its major 
branches, in the development of CVDs.[18-20]
In the general population, the elasticity of the aorta 
decreases more rapidly in men than women.[6,9] In contrary, 
other studies reported an increased stiffness in women, 
Figure 1: Group A: RA patients with aortic stiffness Group B: RA 
patients without aortic stiffness. Mean values of aortic stiffness index 
in case and control groups
but not in men in patients with RA.[20,21] However, this 
study conﬁ  rmed the presence of an increased stiffness of 
the aorta associated with RA in both genders. The male 
and female distribution was nearly similar in both aortic 
stiffness and non-stiffness rheumatoid patients.
It is known that different arterial segments respond 
Table 1: Demographic and clinical studies of both case and control groups
Variables Control group, 
N = 41
Patients with RA (case), N=63 P value
All, 
N = 63
Group A, N = 20 
(31.7%)
Group B, N = 43 
(68.3%)
PP * P**
Age (years) 45.8 ± 7.9 44.1 ± 6.2 52.9 ± 7.1 39.9 ± 5.9 <0.05 <0.05 n.s
Gender
Male (%) N = 22 (54) N = 33 (52) N = 11 (55) N = 22 (51) n.s n.s n.s
Female (%) N = 19 (46) N = 30 (48) N = 9 (45) N = 21 (49) n.s n.s n.s
RA duration (years) – 9 ± 2.3 13 ± 2.9 7 ± 3.1 – <0.05 –
Smoking index 43 ± 5.4  36 ± 6.3 62 ± 5.1 31 ± 7.8 <0.01 <0.05 n.s
SBP (mmHg) 121.9 ± 7.2 122.2 ± 9.2 124.9 ± 7.9 120.1 ± 5.3 n.s n.s n.s
DBP (mmHg) 74.4 ± 3.1 76.3 ± 2.1 75.9 ± 2.5 73.9 ± 1.6 n.s n.s n.s
Mean BP (mmHg) 74.4 ± 3.1 76.3 ± 2.1 75.9 ± 2.5 73.9 ± 1.6 n.s n.s n.s
BMI % 23.6 ± 5.7 25.4 ± 5.2 26.5 ± 5.2 24.4 ± 5.1 n.s n.s n.s
W. circum (cm) 100.3 ± 16.3 103.2 ± 17.2 112.4 ± 11.6 95.5 ± 18.2 <0.01 < 0.05 n.s
Extraarticular m. (%) – N = 21(33) N = 12 (60) N = 9 (21) – <0.05 –
Group A = patients with aortic stiffness; Group B = patients without aortic stiffness; RA = rheumatoid arthritis; BMI = body mass index; SBP = systolic blood pressure; DBP 
= diastolic blood pressure; Mean BP = mean blood pressure; W. circum = waist circumference; N = number of cases; n.s = non signiﬁ  cant; Extraarticular m. = Extraarticular 
manifestations. P = comparison between Group A and control. P* = comparison between Groups A and B.  P** = comparison between all patients and control group.
Table 2: Biochemical studies of both case and control groups
Variables Control group, N = 41 Patients with RA (case), N=63 P value
All, N = 63 Group A, N = 20 (31.7%) Group B, N = 43 (68.3%) PP * P**
HDL mg% 48.1+5.2 44.1 ± 3.9 41.9 ± 4.5 45.1 ± 4.2 n.s n.s n.s
LDL mg% 112.9 ± 9.3 117.7 ± 2.4 127.2 ± 16.7 121.3 ± 15.2 n.s n.s n.s
Triglycerides mg% 146.8 ± 15.6 181.4 ± 14.5 197.5 ± 14.2 187.5 ± 11.9 <0.01 <0.05 <0.05
FPG mg% 83.1 ± 7.2 91.2 ± 7.8 114.8 ± 14.6 101.7 ± 19.9 n.s n.s n.s
CRP 12.3 ± 1.9 22.7 ± 6.2 31.2 ± 4.1 17.2 ± 3.2 <0.01 <0.05 <0.05
RF (positive) – N = 48 (76%) N = 15 (75%) N = 33 (77%) – n.s –
Group A = patients with aortic stiffness; Group B = patients without aortic stiffness; LDL = low density lipoprotein; HDL = high density lipoprotein, N = number of cases; n.s 
= non signiﬁ  cant; CRP= C reactive protein; FPS = fasting plasma glucose; RF = rheumatoid factor. P = comparison between Group A and control. P* =comparison between 
Groups A and B. P** = comparison between all patients and control group.Sliem and Nasr: Aortic elasticity in rheumatoid arthritis
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differently to aging. Aorta, an elastic artery, loses its 
compliance with advancing age, whereas compliance in 
the peripheral, predominantly muscular, arteries appears 
less closely related to age.[22] In current data, age was an 
independent predictor of aortic stiffness.
Duration of rheumatoid seems to have positive reﬂ  ection 
on the presence of aortic stiffness. Mean disease duration 
was signiﬁ  cantly higher in RA patients with aortic stiffness 
than those without. As detected in the current study, 75% 
of patients with aortic stiffness had disease duration 
more than 10 years. This could be explained by the fact 
that inﬂ  ammatory cytokines play an important role in 
the pathogenesis of RA and contribute to mediate not 
only local acute events but also the systemic response.
[23] Therefore, one can speculate that chronic cytokine 
release may lead to the deposition of cellular and lipid 
debris, producing the characteristic arterial wall changes 
and dysfunctional vasculature.
Tobacco smoking was further categorized by us after 
calculation of smoking index. Smoking is regarded to be 
a powerful predictor of CVD in the general population. 
Smoking has also been reported to be a predictor of 
the RA disease itself.[24] Thus, tempting to believe that 
smoking would be the cause of an increased CVD in RA 
patients. Its’ burden on the decrease of aortic elasticity 
was reported. Our results are in agreement with other 
studies.[2,25]
Previous studies have shown that visceral fat in young 
healthy individuals and older adults is associated with 
increased central arterial stiffness.[26] This study conﬁ  rms 
this result. In agreement with a recent study by Vizzardi 
et al.[10] we observed that mean of abdominal adiposity 
as measured by waist circumference was strongly and 
adversely higher in rheumatoid patients with aortic stiffness, 
whereas BMI as a measure of general adiposity was not. 
These results suggest that the rheumatoid–arterial stiffness 
relationship may be mediated in part through increasing 
central obesity. In general, adipocytes, in particular from 
visceral abdominal regions, produce several bioactive 
peptides which in turn impact on vascular structure and 
function.[27]
Van Doornum et al, reported that stiffness of the aorta 
tended to be higher in patients with recently diagnosed 
severe extraarticular manifestations, and there was a 
significant association between disability and aortic 
stiffness.[28] In our study, the presence or absence of 
extraarticular manifestations showed signiﬁ  cant reﬂ  ection 
on the state of aortic elasticity. This is in agreement with 
other studies. The scientists from three different Swedish 
universities examined the distensibility and the diameter 
of the abdominal aorta and the common carotid artery 
by echo-tracking ultrasonography in 101 patients with 
RA. The results were compared with healthy individuals 
from a corresponding age group. In the RA cohort, 
patients with extraarticular manifestations tended to have 
greater stiffness of the aorta. Also disability, as indicated 
by a Higher Health Assessment Questionnaire Score, was 
associated with increased aortic stiffness.[18,29] This indicates 
that other several disease severity may have an impact on 
arterial wall abnormalities in patients with RA.
However, increased distending pressure tends to reduce 
the elasticity of a given arterial segment through the 
recruitment of collagen ﬁ  bers. In addition, several studies 
have shown that arterial stiffness is increased in individuals 
with diabetes.[9,25,30] Nevertheless, in our study, most of the 
patients were nearly normotensive and euglycemic, such 
the association was not held.
We should point out that, in current data the total lipids 
had insigniﬁ  cant impact on aortic stiffness. When the 
components of the lipids were considered separately, aortic 
stiffness showed direct associations only with triglycerides. 
Similar conclusion was reported in a previous study of 
aortic stiffness in metabolic syndrome.[16]
CRP levels predict outcome in healthy individuals and 
patients with atherosclerosis. The increased CRP levels 
predict cardiovascular morbidity in early inﬂ  ammatory 
polyarthritis. Increased CRP and erythrocyte sedimentation 
rate (ESR) are associated with greater thickness of the 
carotid artery intima-media in RA and also in healthy 
subjects.[31] Others have found CRP levels to be associated 
with aortic pulse wave velocity in healthy individuals and 
in patients with systemic vasculitis.[32] Some authors did 
not ﬁ  nd any association between current CRP levels and 
aortic stiffness.[33] However, in this study current CRP 
levels were higher in rheumatoid patients with aortic 
stiffness than those without, suggesting that inﬂ  ammation 
may be involved in arterial stiffening. Anti-inﬂ  ammatory 
strategies may, therefore, be of benefit in reducing 
arterial stiffness and thus CVD.[34] In addition, Kaisa et 
al. suggested that effective control of inﬂ  ammation may 
reduce cardiovascular risk in patients with RA as it improves 
arterial stiffness and endothelial function, both of which 
are established surrogate measures of cardiovascular risk. 
Moreover, RA may serve as a useful model to investigate 
the effects of other immunomodulatory agents on arterial 
stiffness and endothelial function.[35]Sliem and Nasr: Aortic elasticity in rheumatoid arthritis
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CONCLUSION
RA is associated with decreased elasticity of the aorta 
in both genders, and such changes seem to be higher 
in patients with extraarticular disease severity. Arterial 
stiffness may act as a marker for the development of 
future CVD in RA. Measurement of arterial stiffness 
will become an increasingly important part of the 
process of risk assessment, and may possibly improve 
the monitoring of therapy. Various risk factors have 
impact on the increased arterial stiffness parameters. 
Apart from the dominant effect of aging, they include 
smoking, visceral obesity, triglyceride, CRP, hypertension, 
and hyperglycemia. Parallel to treatment of rheumatoid, 
appropriate and watchful dealing with all associated risk 
factors should be considered. The main limitation of 
the study was the sample size. Additional studies will 
be needed to assess the effect of anti-inﬂ  ammatory and 
immunomodulatory agents to decrease arterial stiffness 
and the impact of the rheumatoid disease activity on the 
severity of arterial stiffness.
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